1 INTRODUCTION
==============

DNA methylation is an important epigenetic mark in mammals. In addition to the extensively studied 5-methylcytosine (5-mC) modification, its oxidation product, 5-hydroxymethylcytosine (5-hmC), has been observed at substantial levels in both somatic and embryonic stem cells ([@btt459-B9]; [@btt459-B11]). Recent studies of 5-hmC in mouse TET knock-out models ([@btt459-B5]), mouse zygotic development ([@btt459-B4]) and multiple cell types ([@btt459-B2]; [@btt459-B6]; [@btt459-B8]; [@btt459-B10]) suggest that 5-hmC is involved in epigenetic regulation.

The current most comprehensive and accurate method for profiling cytosine methylation is bisulfite sequencing (BS-seq). Treatment with sodium bisulfite converts unmethylated cytosines to uracils, but does not distinguish between 5-mC and 5-hmC ([@btt459-B3]), and consequently the yield of methylation from BS-seq is the sum of 5-mC and 5-hmC levels. Two recently developed techniques, oxidative bisulfite sequencing (oxBS-seq) ([@btt459-B1]) and [T]{.ul}et-[A]{.ul}ssisted [B]{.ul}isulfite sequencing (TAB-seq) ([@btt459-B12]), provide high-throughput single-base resolution measurements of 5-mC and 5-hmC, respectively. Any two of BS-seq, TAB-seq or oxBS-seq can be combined to profile both the 5-mC and 5-hmC methylomes of a cell population, and especially when studying 5-hmC, proper interpretation of results depends on having some estimate of the 5-mC level. However, naive manipulation of read count frequencies from independent sequencing experiments often produces two kinds of 'overshoot' problems in estimating 5-mC and 5-hmC levels. When combining BS-seq with TAB-seq, the 5-mC level at a given CpG site can be estimated by subtracting the 5-hmC level (TAB-seq) from the combined 5-mC + 5-hmC level (BS-seq). The result can be negative, because of random sampling (or systematic error) in each experiment. Similarly, combining TAB-seq and oxBS-seq could lead to estimates of 5-mC and 5-hmC levels exceeding 100%. These overshoot sites may constitute a substantial proportion. In one dataset based on oxBS-seq technology, 17% of CpG sites captured by reduced representation bisulfite sequencing (RRBS) and oxRRBS experiments exhibited overshoot ([@btt459-B1]). To fully leverage the information in these data requires some method for making consistent estimates of 5-mC and 5-hmC levels.

We present maximum likelihood methylation levels (MLML) for simultaneous estimation of 5-mC and 5-hmC, combining data from any two of BS-seq, TAB-seq or oxBS-seq, or all three when available. Our estimates are consistent in that 5-mC and 5-hmC levels are non-negative, and never sum over 1. In an important subset of cases, our estimates are not only consistent but also show significantly greater accuracy at sites with lower coverage.

2 METHODS
=========

Each of BS-seq, TAB-seq and oxBS-seq provides some amount of information about both the 5-mC and 5-hmC levels. Our approach is to combine information from any pair or all three of these experiments, and arrive at maximum likelihood estimates (MLEs) for the 5-mC and 5-hmC levels. A similar method has been developed in the context of haplotype frequency estimation from pooled sequencing ([@btt459-B7]). To explain our method, we assume the data are from TAB-seq and BS-seq experiments for the same biological sample. The more general formulation is provided in [Supplementary Information](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btt459/-/DC1).

Focusing on an individual CpG site, let *p~m~* denote the methylation level (a probability), *p~h~* the hydroxymethylation and the level of unmethylated C. In the TAB-seq experiment, let *h* denote the number of C reads mapping over the CpG site, and let *g* denote the T reads mapping over the same CpG. The total reads covering the CpG site in the TAB-seq experiment is then *h* + *g*. Similarly, let *t* denote the number of C reads mapping over the site in the BS-seq experiment, whereas *u* denotes the number of T reads, and the total reads covering the CpG in the BS-seq experiment is . If values for *p~m~* and *p~h~* are known, *h* and *u* are binomial random variables, i.e. , and : Given observations of , when no overshoot would result, we use the frequencies to estimate . In this case, the frequencies directly give MLEs. At overshoot sites, we introduce latent variables and use expectation maximization to approximate the MLE for **p**. Let () be the number of C (T) reads in BS-seq (TAB-seq) that correspond to 5-mCs. Then () is the number of C (T) reads corresponding to 5-hmC (unmethylated C). The complete data likelihood is then where is a multinomial p.m.f. Estimates for *p~h~* and *p~m~* are then computed by expectation maximization algorithm to account for the latent and ([Supplementary Information](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btt459/-/DC1)). The MLEs can be compared with binomial confidence intervals around corresponding frequency estimates if direct readouts (e.g. for 5-hmC in the case of TAB-seq) are available. When estimates fall outside the specified confidence interval, sites are flagged as being 'strongly' inconsistent. An overabundance of such sites might suggest systematic error.

3 RESULTS
=========

To understand the properties of our estimators and the frequency method, we used simulations with fixed coverage and precisely set levels for 5-mC and 5-hmC, assuming the experiments were BS-seq and TAB-seq. The case of BS-seq and oxBS-seq is symmetric with the estimates for *p~h~* and *p~m~* exchanged. For each valid combination of 5-mC and 5-hmC levels from , we simulated from binomial distributions for both BS-seq and TAB-seq. Estimates for *p~h~* and *p~m~* were made using the maximum likelihood method and the frequency method, which estimate *p~h~* using and *p~m~* using . The relative error () for both estimation methods was computed and then averaged over 100 000 simulations for each parameter combination. The average estimation errors are presented in [Supplementary Table S1](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btt459/-/DC1). Estimates of *p~h~* are more accurate using MLML, especially at lower values of *p~h~* and low coverage. For example, when the true values are , the MLML reduces the average relative error by \>23% at overshoot sites compared with frequency estimates when the coverage is , and this reduction in error increases to 57% for such sites covered only . The trend for errors of *p~h~* estimates is shown in [Figure 1](#btt459-F1){ref-type="fig"}a, indicating the accuracy advantage for MLML as a function of coverage. The simulation also revealed substantial amounts of overshoot sites under different 5-mC and 5-hmC level combinations ([Fig. 1](#btt459-F1){ref-type="fig"}b, [Supplementary Tables](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btt459/-/DC1)). Fig. 1.Accuracy is improved at lower coverage using MLML (BS-seq + TAB-seq). (**a**) Average absolute errors of 5-hmC level estimates at overshoot sites. (**b**) Proportion of overshoot sites in simulated data
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